abstract |
The present invention provides an antibody capable of binding interleukin 4 (IL-4) receptor (IL-4R). In addition, the present invention provides nucleic acid sequences encoding the antibodies, vectors comprising the nucleic acid sequences, and host cells transformed or transfected with the vectors. Further, the present invention provides methods for producing the antibodies of the present invention, medical uses of the antibodies, and kits comprising the antibodies. |